{"id":24423,"date":"2022-01-12T14:39:45","date_gmt":"2022-01-12T11:39:45","guid":{"rendered":"https:\/\/zdmaa.com\/tumor-mutation-measurement-may-predict-treatment-success\/"},"modified":"2022-01-13T03:24:00","modified_gmt":"2022-01-13T00:24:00","slug":"tumor-mutation-measurement-may-predict-treatment-success","status":"publish","type":"post","link":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/","title":{"rendered":"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir"},"content":{"rendered":"<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span class=\"\" style=\"vertical-align: inherit;\">T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir<\/span><\/span><\/span><\/span><\/p>\n<div>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">ABD G\u0131da ve \u0130la\u00e7 Dairesi (FDA) ilk kontrol noktas\u0131 inhibit\u00f6r\u00fc ilac\u0131 ipilimumab&#8217;\u0131 (Yervoy) onaylad\u0131\u011f\u0131ndan beri<\/span><\/span><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">) 2011 y\u0131l\u0131nda cilt kanseri tedavisi i\u00e7in bu imm\u00fcnoterapiler, artan kanser \u00e7e\u015fitlili\u011fine sahip hastalara fayda sa\u011flam\u0131\u015ft\u0131r. <\/span><span style=\"vertical-align: inherit;\">\u0130la\u00e7lar\u0131n potansiyelinden motive olan klinisyenler ve ara\u015ft\u0131rmac\u0131lar, bir tedavinin daha fazla kanser i\u00e7in ne zaman uygulanabilir olabilece\u011fini daha iyi tahmin etmenin ve daha y\u00fcksek hasta y\u00fczdesinde daha iyi sonu\u00e7lar g\u00f6stermenin yeni yollar\u0131n\u0131 ara\u015ft\u0131r\u0131yorlar. <\/span><span style=\"vertical-align: inherit;\">B\u00f6yle bir \u00f6nlem, ara\u015ft\u0131rmac\u0131lar\u0131n t\u00fcm\u00f6r i\u00e7inde bulunan DNA mutasyonlar\u0131n\u0131n say\u0131s\u0131na dayanan t\u00fcm\u00f6r mutasyon y\u00fck\u00fc (TMB) dedi\u011fi \u015feydir. <\/span><span style=\"vertical-align: inherit;\">Bilim adamlar\u0131, kontrol noktas\u0131 inhibit\u00f6rlerine kanser yan\u0131t\u0131n\u0131n potansiyel bir g\u00f6stergesi olarak bazal metabolik h\u0131z\u0131 \u00f6l\u00e7menin yollar\u0131n\u0131 ara\u015ft\u0131r\u0131yorlar. <\/span><span style=\"vertical-align: inherit;\">Phoenix Hastanesi&#8217;nde t\u0131bbi onkolog olan Ashish Sangal, &#8220;T\u00fcm\u00f6r mutasyon y\u00fck\u00fc, imm\u00fcnoterapiye ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin kansere kar\u015f\u0131 hareket etmesine izin verecek \u015fekilde yan\u0131t verebilecek t\u00fcm\u00f6rleri tan\u0131mlaman\u0131n iyi bir yoludur&#8221; diyor.<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Kanser, h\u00fccrelerin i\u00e7indeki DNA de\u011fi\u015fti\u011finde veya mutasyona u\u011frad\u0131\u011f\u0131nda geli\u015fir ve h\u00fccrelerin d\u00fczg\u00fcn \u00e7al\u0131\u015fmas\u0131n\u0131 engeller. <\/span><span style=\"vertical-align: inherit;\">\u00c7o\u011fu durumda, bu mutasyonlar kusurlu h\u00fccrelerin \u00e7o\u011falmas\u0131na ve b\u00fcy\u00fcmesine izin vererek t\u00fcm\u00f6rler olu\u015fturabilir. <\/span><span style=\"vertical-align: inherit;\">Bilim adamlar\u0131, bir t\u00fcm\u00f6rdeki mutasyon say\u0131s\u0131 ne kadar y\u00fcksek olursa veya bazal metabolizma h\u0131z\u0131 ne kadar y\u00fcksek olursa, bu mutasyonlardan bir veya daha fazlas\u0131n\u0131n imm\u00fcnoterapiye yan\u0131t verme olas\u0131l\u0131\u011f\u0131n\u0131n o kadar y\u00fcksek oldu\u011funa inanmaktad\u0131r.<\/span><\/span><\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">T\u0131bbi onkolog Ashish Sangal, &#8220;Ne kadar \u00e7ok mutasyon olursa, cevap o kadar iyi olur. Bu nedenle, mutasyon say\u0131s\u0131 ne kadar y\u00fcksek olursa, imm\u00fcnoterapi kullan\u0131m\u0131ndan yararlanma \u015fans\u0131 o kadar y\u00fcksek olur&#8221; diyor. <\/span><span style=\"vertical-align: inherit;\">\u0130mm\u00fcnoterapi ila\u00e7lar\u0131, kanser h\u00fccrelerinin yay\u0131lmas\u0131na izin veren sinyalleri kesmek i\u00e7in tasarlanm\u0131\u015ft\u0131r. <\/span><span style=\"vertical-align: inherit;\">Ba\u011f\u0131\u015f\u0131kl\u0131k sisteminden saklan\u0131yor. <\/span><span style=\"vertical-align: inherit;\">Kanser h\u00fccreleri, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin y\u00fczeyindeki protein resept\u00f6rlerine, ba\u011f\u0131\u015f\u0131kl\u0131k kontrol noktalar\u0131ndan ge\u00e7tikleri zor sinyaller g\u00f6nderir. <\/span><span style=\"vertical-align: inherit;\">Bu kontrol noktalar\u0131 olmazsa, ba\u011f\u0131\u015f\u0131kl\u0131k sistemi sa\u011fl\u0131kl\u0131 h\u00fccrelere sald\u0131rabilir. <\/span><span style=\"vertical-align: inherit;\">Bir kontrol noktas\u0131 inhibit\u00f6r\u00fcn\u00fcn belirli bir kanserde i\u015fe yaray\u0131p yaramad\u0131\u011f\u0131n\u0131 belirlemek i\u00e7in iki ana kriter kullan\u0131l\u0131r:<\/span><\/span><\/p>\n<ul>\n<li><strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">PD L1<\/span><\/span><\/strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> , ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinde PD-1 resept\u00f6r\u00fcne ba\u011flanan kanser h\u00fccrelerinde s\u0131kl\u0131kla bulunan bir resept\u00f6rd\u00fcr. <\/span><span style=\"vertical-align: inherit;\">\u0130ki resept\u00f6r temas etti\u011finde, kanser h\u00fccresi, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccresine bir tehdit olmad\u0131\u011f\u0131n\u0131 s\u00f6yleyen bir sinyal g\u00f6ndererek, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccresinin ayr\u0131lmas\u0131na ve ba\u015fka tehditler aramas\u0131na neden olabilir. <\/span><span style=\"vertical-align: inherit;\">Kontrol noktas\u0131 inhibit\u00f6rleri bu sinyali keserek ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin kanser h\u00fccrelerini daha iyi tan\u0131mas\u0131na ve sald\u0131rmas\u0131na izin verir.<\/span><\/span><\/li>\n<li><strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Mikro uydu karars\u0131zl\u0131\u011f\u0131 (MSI)<\/span><\/span><\/strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> , bir h\u00fccrenin DNA&#8217;s\u0131n\u0131n kendini onarmas\u0131n\u0131 zorla\u015ft\u0131ran ve bir\u00e7ok t\u00fcm\u00f6r\u00fcn olu\u015fmas\u0131na ve b\u00fcy\u00fcmesine neden olan kontrols\u00fcz h\u00fccre b\u00fcy\u00fcmesi tipine yol a\u00e7abilen genetik bir mutasyondur. <\/span><span style=\"vertical-align: inherit;\">Ara\u015ft\u0131rmalar, y\u00fcksek MSI&#8217;l\u0131 t\u00fcm\u00f6rlerin kontrol noktas\u0131 inhibit\u00f6rlerine daha iyi yan\u0131t verebilece\u011fini g\u00f6stermi\u015ftir. <\/span><span style=\"vertical-align: inherit;\">Ge\u00e7en y\u0131l ABD G\u0131da ve \u0130la\u00e7 Dairesi (FDA), kanser ilac\u0131 pembrolizumab&#8217;\u0131 (Keytruda) onaylayarak \u00e7ok \u00f6nemli bir ad\u0131m att\u0131. <\/span><\/span><sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">\u00ae<\/span><\/span><\/sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> ) y\u00fcksek MSI i\u00e7eri\u011fine sahip kanserlerin tedavisi i\u00e7in. <\/span><span style=\"vertical-align: inherit;\">Bir kanser tedavisinin ilk onay\u0131, t\u00fcm\u00f6r\u00fcn v\u00fccuttaki birincil konumuna de\u011fil, kanserin DNA&#8217;s\u0131nda bulunan spesifik bir genetik \u00f6zelli\u011fe dayan\u0131yordu.<\/span><\/span><\/li>\n<\/ul>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">\u00d6yleyse, klinisyenlerin bir kontrol noktas\u0131 inhibit\u00f6r\u00fcn\u00fcn potansiyelini \u00f6l\u00e7mek i\u00e7in halihaz\u0131rda iki yolu varsa, neden bir ba\u015fkas\u0131na ihtiya\u00e7 duysunlar? <\/span><span style=\"vertical-align: inherit;\">Ara\u015ft\u0131rmac\u0131lar, \u015fu anda kontrol noktas\u0131 inhibit\u00f6rleri ile tedavi edilmeyen baz\u0131 kanserlerin y\u00fcksek BMR&#8217;ye sahip olabilece\u011fine inan\u0131yor. <\/span><span style=\"vertical-align: inherit;\">Ayr\u0131ca, aktifle\u015ftirilmi\u015f ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleri her zaman neye sald\u0131racaklar\u0131n\u0131 bilemezler. <\/span><span style=\"vertical-align: inherit;\">Ba\u011f\u0131\u015f\u0131kl\u0131k tepkisi, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleri antijen ad\u0131 verilen molek\u00fclleri tespit etti\u011finde tetiklenir. <\/span><span style=\"vertical-align: inherit;\">Ara\u015ft\u0131rmac\u0131lar, bazal metabolizma h\u0131z\u0131 y\u00fcksek olan t\u00fcm\u00f6rlerdeki kanser h\u00fccrelerinin, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerini \u00e7ekebilen kanser h\u00fccreleri \u00fczerindeki resept\u00f6rler olan daha fazla yeni antijen i\u00e7erebilece\u011fine inan\u0131yor.<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Ara\u015ft\u0131rmac\u0131lar, kontrol noktas\u0131 inhibit\u00f6rlerinin ve di\u011fer kanser tedavilerinin etkinli\u011fini tahmin etmek i\u00e7in TMB&#8217;nin nas\u0131l kullan\u0131labilece\u011fini belirlemek i\u00e7in \u00e7ok say\u0131da klinik deney y\u00fcr\u00fct\u00fcyor. <\/span><span style=\"vertical-align: inherit;\">Bilim adamlar\u0131 ayr\u0131ca kanserde ka\u00e7 tane mutasyon oldu\u011funu ve BMR&#8217;ye k\u0131yasla neyin y\u00fcksek olarak kabul edilebilece\u011fini test etmek i\u00e7in g\u00fcvenilir yollar geli\u015ftirmeye \u00e7al\u0131\u015f\u0131yorlar. <\/span><span style=\"vertical-align: inherit;\">&#8220;\u0130leriye d\u00f6n\u00fck olarak, kesinlikle bu \u00fc\u00e7 \u015feyin (PD-L1, MSI, t\u00fcm\u00f6r mutasyon y\u00fck\u00fc) imm\u00fcnoterapilerin nas\u0131l kullan\u0131laca\u011f\u0131n\u0131 ve hangi kanser t\u00fcrlerinin cevap verip veremeyece\u011fini belirlemeye yard\u0131mc\u0131 olmak i\u00e7in kullan\u0131laca\u011f\u0131 bir noktaya geliyoruz&#8221; diyor Dr. . Sangal.<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir ABD G\u0131da ve \u0130la\u00e7 Dairesi (FDA) ilk kontrol noktas\u0131 inhibit\u00f6r\u00fc ilac\u0131 ipilimumab&#8217;\u0131 (Yervoy) onaylad\u0131\u011f\u0131ndan beri) 2011 y\u0131l\u0131nda cilt kanseri tedavisi i\u00e7in bu imm\u00fcnoterapiler, artan kanser \u00e7e\u015fitlili\u011fine sahip hastalara fayda sa\u011flam\u0131\u015ft\u0131r. \u0130la\u00e7lar\u0131n potansiyelinden motive olan klinisyenler ve ara\u015ft\u0131rmac\u0131lar, bir tedavinin daha fazla kanser i\u00e7in ne zaman uygulanabilir olabilece\u011fini daha iyi &hellip;<\/p>\n","protected":false},"author":1,"featured_media":23278,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-24423","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-tr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir - zdmaa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir - zdmaa\" \/>\n<meta property=\"og:description\" content=\"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir ABD G\u0131da ve \u0130la\u00e7 Dairesi (FDA) ilk kontrol noktas\u0131 inhibit\u00f6r\u00fc ilac\u0131 ipilimumab&#8217;\u0131 (Yervoy) onaylad\u0131\u011f\u0131ndan beri) 2011 y\u0131l\u0131nda cilt kanseri tedavisi i\u00e7in bu imm\u00fcnoterapiler, artan kanser \u00e7e\u015fitlili\u011fine sahip hastalara fayda sa\u011flam\u0131\u015ft\u0131r. \u0130la\u00e7lar\u0131n potansiyelinden motive olan klinisyenler ve ara\u015ft\u0131rmac\u0131lar, bir tedavinin daha fazla kanser i\u00e7in ne zaman uygulanabilir olabilece\u011fini daha iyi &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/\" \/>\n<meta property=\"og:site_name\" content=\"zdmaa\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-12T11:39:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-13T00:24:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/alternative-medicine-g2fc1b88c9_640.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"425\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/\",\"url\":\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/\",\"name\":\"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir - zdmaa\",\"isPartOf\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/alternative-medicine-g2fc1b88c9_640.jpg\",\"datePublished\":\"2022-01-12T11:39:45+00:00\",\"dateModified\":\"2022-01-13T00:24:00+00:00\",\"author\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\"},\"breadcrumb\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#primaryimage\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/alternative-medicine-g2fc1b88c9_640.jpg\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/alternative-medicine-g2fc1b88c9_640.jpg\",\"width\":640,\"height\":425,\"caption\":\"Tumor Mutation Measurement May Predict Treatment Success\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\/\/zdmaa.com\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#website\",\"url\":\"https:\/\/zdmaa.com\/tr\/ro\/\",\"name\":\"zdmaa\",\"description\":\"zdmaa\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/zdmaa.com\/tr\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775954700\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775954700\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/zdmaa.com\"],\"url\":\"https:\/\/zdmaa.com\/tr\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir - zdmaa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/","og_locale":"tr_TR","og_type":"article","og_title":"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir - zdmaa","og_description":"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir ABD G\u0131da ve \u0130la\u00e7 Dairesi (FDA) ilk kontrol noktas\u0131 inhibit\u00f6r\u00fc ilac\u0131 ipilimumab&#8217;\u0131 (Yervoy) onaylad\u0131\u011f\u0131ndan beri) 2011 y\u0131l\u0131nda cilt kanseri tedavisi i\u00e7in bu imm\u00fcnoterapiler, artan kanser \u00e7e\u015fitlili\u011fine sahip hastalara fayda sa\u011flam\u0131\u015ft\u0131r. \u0130la\u00e7lar\u0131n potansiyelinden motive olan klinisyenler ve ara\u015ft\u0131rmac\u0131lar, bir tedavinin daha fazla kanser i\u00e7in ne zaman uygulanabilir olabilece\u011fini daha iyi &hellip;","og_url":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/","og_site_name":"zdmaa","article_published_time":"2022-01-12T11:39:45+00:00","article_modified_time":"2022-01-13T00:24:00+00:00","og_image":[{"width":640,"height":425,"url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/alternative-medicine-g2fc1b88c9_640.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"admin","Tahmini okuma s\u00fcresi":"4 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/","url":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/","name":"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir - zdmaa","isPartOf":{"@id":"https:\/\/zdmaa.com\/tr\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#primaryimage"},"image":{"@id":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#primaryimage"},"thumbnailUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/alternative-medicine-g2fc1b88c9_640.jpg","datePublished":"2022-01-12T11:39:45+00:00","dateModified":"2022-01-13T00:24:00+00:00","author":{"@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3"},"breadcrumb":{"@id":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#primaryimage","url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/alternative-medicine-g2fc1b88c9_640.jpg","contentUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/alternative-medicine-g2fc1b88c9_640.jpg","width":640,"height":425,"caption":"Tumor Mutation Measurement May Predict Treatment Success"},{"@type":"BreadcrumbList","@id":"https:\/\/zdmaa.com\/tr\/tumor-mutation-measurement-may-predict-treatment-success\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/zdmaa.com\/tr\/"},{"@type":"ListItem","position":2,"name":"T\u00fcm\u00f6r mutasyonunun \u00f6l\u00e7\u00fclmesi tedavi ba\u015far\u0131s\u0131n\u0131 \u00f6ng\u00f6rebilir"}]},{"@type":"WebSite","@id":"https:\/\/zdmaa.com\/tr\/ro\/#website","url":"https:\/\/zdmaa.com\/tr\/ro\/","name":"zdmaa","description":"zdmaa","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zdmaa.com\/tr\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3","name":"admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/image\/","url":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775954700","contentUrl":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775954700","caption":"admin"},"sameAs":["https:\/\/zdmaa.com"],"url":"https:\/\/zdmaa.com\/tr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/24423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/comments?post=24423"}],"version-history":[{"count":1,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/24423\/revisions"}],"predecessor-version":[{"id":24474,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/24423\/revisions\/24474"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/media\/23278"}],"wp:attachment":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/media?parent=24423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/categories?post=24423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/tags?post=24423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}